Skip to content
Home/Companies/Biotech/Oncopeptides

Oncopeptides

Biotech·Sweden·Exited 2017·Held 4yr
Entry
2013
Hold
4yr
Exit
2017

Who owns Oncopeptides?

Oncopeptides was owned by Industrifonden through Industrifonden Evergreen (1991 vintage) from 2013 to 2017, exited via IPO.

Hand-verified · updated 2026-08-17

Industrifonden
Investor
Industrifonden
Industrifonden Evergreen · 1991 · VC

Key facts

HQSweden
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2017

More from Industrifonden Evergreen

Other portfolio companies in the same fund.

Agteria Biotech
Active
AgTechSweden· 2025
Echandia
Active
ClimateTechSweden· 2025
Tribune Therapeutics
Active
BiotechSweden· 2025
Adamant Quanta
Active
Deep TechSweden· 2023
AlixLabs
Active
Deep TechSweden· 2023
HVR Cardio
Active
MedTechSweden· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Oncopeptides

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Oncopeptides?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Oncopeptides.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue